abstract abstract since the discovery in the 1980s that nitric oxide (no) is in fact the elusive endothelium-derived relaxing factor, it has become evident that no is not only a major cardiovascular signalling molecule, but that changes in its bioavailability are crucial in determining whether atherosclerosis will develop or not.